{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T16:21:07Z","timestamp":1788970867796,"version":"build-2803163510"},"reference-count":46,"publisher":"Impact Journals, LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"DOI":"10.18632\/aging.206028","type":"journal-article","created":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T16:38:51Z","timestamp":1729183131000},"source":"Crossref","is-referenced-by-count":3,"title":["Angiotensin-(1-7) relieves behavioral defects and \u03b1-synuclein expression through NEAT1\/miR-153-3p axis in Parkinson\u2019s disease"],"prefix":"10.18632","author":[{"given":"Qing","family":"Gao","sequence":"first","affiliation":[{"name":"Department of Neurology, Nanjing First Hospital, Nanjing Medical University, Nanjing 210006, Jiangsu, P.R. China"},{"name":"Department of Nuclear Medicine, Nanjing First Hospital, Nanjing Medical University, Nanjing 210006, Jiangsu, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyuan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Nanjing First Hospital, Nanjing Medical University, Nanjing 210006, Jiangsu, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Nanjing First Hospital, Nanjing Medical University, Nanjing 210006, Jiangsu, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Neurology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyu","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Nanjing First Hospital, Nanjing Medical University, Nanjing 210006, Jiangsu, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Deng","sequence":"additional","affiliation":[{"name":"Department of Neurology, Nanjing First Hospital, China Pharmaceutical University, Nanjing 210006, Jiangsu, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Nanjing First Hospital, Nanjing Medical University, Nanjing 210006, Jiangsu, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Xue","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Nanjing First Hospital, Nanjing Medical University, Nanjing 210006, Jiangsu, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Duan","sequence":"additional","affiliation":[{"name":"Department of Neurology, Nanjing First Hospital, Nanjing Medical University, Nanjing 210006, Jiangsu, P.R. China"},{"name":"Department of Nuclear Medicine, Nanjing First Hospital, Nanjing Medical University, Nanjing 210006, Jiangsu, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2024,10,17]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/S1474-4422(16)30230-7","article-title":"The epidemiology of Parkinson\u2019s disease: risk factors and prevention.","volume":"1","author":"Schwarzschild","year":"2016","journal-title":"Lancet Neurol"},{"key":"2","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S1474-4422(21)00030-2","article-title":"Challenges in the diagnosis of Parkinson\u2019s disease.","volume":"2","author":"Poewe","year":"2021","journal-title":"Lancet Neurol"},{"key":"3","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/S1474-4422(21)00061-2","article-title":"Progress towards therapies for disease modification in Parkinson\u2019s disease.","volume":"2","author":"Foltynie","year":"2021","journal-title":"Lancet Neurol"},{"key":"4","doi-asserted-by":"publisher","first-page":"5847","DOI":"10.1007\/s12035-017-0805-y","article-title":"Paracrine and Intracrine Angiotensin 1-7\/Mas Receptor Axis in the Substantia Nigra of Rodents, Monkeys, and Humans.","volume":"5","author":"Labandeira-Garcia","year":"2018","journal-title":"Mol Neurobiol"},{"key":"5","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1021\/acschemneuro.1c00797","article-title":"Angiotensin-Converting Enzyme 2 Activation Mitigates Behavioral Deficits and Neuroinflammatory Burden in 6-OHDA Induced Experimental Models of Parkinson\u2019s Disease.","volume":"1","author":"Shukla","year":"2022","journal-title":"ACS Chem Neurosci"},{"key":"6","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.3390\/biom12101429","article-title":"Impact of the Renin-Angiotensin System on the Pathogeny and Pharmacotherapeutics of Neurodegenerative Diseases.","volume":"1","author":"Bild","year":"2022","journal-title":"Biomolecules"},{"key":"7","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3233\/JAD-181000","article-title":"Chronic Angiotensin 1-7 Infusion Prevents Angiotensin-II-Induced Cognitive Dysfunction and Skeletal Muscle Injury in a Mouse Model of Alzheimer\u2019s Disease.","volume":"6","author":"Kim-Mitsuyama","year":"2019","journal-title":"J Alzheimers Dis"},{"key":"8","doi-asserted-by":"publisher","first-page":"7686","DOI":"10.3390\/ijms23147686","article-title":"Renin-Angiotensin System in Huntington\u2019s Disease: Evidence from Animal Models and Human Patients.","volume":"2","author":"Guatimosim","year":"2022","journal-title":"Int J Mol Sci"},{"key":"9","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.tiv.2018.04.005","article-title":"Neuroprotective effect of angiotensin-(1-7) against rotenone-induced oxidative damage in CATH.a neurons.","volume":"5","author":"Zhang","year":"2018","journal-title":"Toxicol In Vitro"},{"key":"10","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1002\/jcp.30932","article-title":"miRNA in Parkinson\u2019s disease: From pathogenesis to theranostic approaches.","volume":"23","author":"Vellingiri","year":"2023","journal-title":"J Cell Physiol"},{"key":"11","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.apsb.2020.10.001","article-title":"Long non-coding RNAs: From disease code to drug role.","volume":"1","author":"Zhang","year":"2021","journal-title":"Acta Pharm Sin B"},{"key":"12","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s10735-020-09931-3","article-title":"LncRNA SNHG1 promotes neuronal injury in Parkinson\u2019s disease cell model by miR-181a-5p\/CXCL12 axis.","volume":"5","author":"Zhao","year":"2021","journal-title":"J Mol Histol"},{"key":"13","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.neuroscience.2016.03.042","article-title":"MiR-133b ameliorates axon degeneration induced by MPP(+) via targeting RhoA.","volume":"32","author":"Xie","year":"2016","journal-title":"Neuroscience"},{"key":"14","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.18632\/aging.101466","article-title":"CircSNCA downregulation by pramipexole treatment mediates cell apoptosis and autophagy in Parkinson\u2019s disease by targeting miR-7.","volume":"1","author":"Zhang","year":"2018","journal-title":"Aging (Albany NY)"},{"key":"15","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12929-020-00636-z","article-title":"Functional roles and networks of non-coding RNAs in the pathogenesis of neurodegenerative diseases.","volume":"2","author":"Kuo","year":"2020","journal-title":"J Biomed Sci"},{"key":"16","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s12031-020-01660-2","article-title":"NEAT1 Decreasing Suppresses Parkinson\u2019s Disease Progression via Acting as miR-1301-3p Sponge.","volume":"7","author":"Chen","year":"2021","journal-title":"J Mol Neurosci"},{"key":"17","doi-asserted-by":"publisher","first-page":"841692","DOI":"10.3389\/fimmu.2022.841692","article-title":"Angiotensin-(1-7) as a Potential Therapeutic Strategy for Delayed Cerebral Ischemia in Subarachnoid Hemorrhage.","volume":"1","author":"Zanier","year":"2022","journal-title":"Front Immunol"},{"key":"18","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1021\/cn500363g","article-title":"The implications of angiotensin-converting enzymes and their modulators in neurodegenerative disorders: current and future perspectives.","volume":"6","author":"Kaur","year":"2015","journal-title":"ACS Chem Neurosci"},{"key":"19","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.bcp.2018.01.047","article-title":"Angiotensin 1-7 ameliorates 6-hydroxydopamine lesions in hemiparkinsonian rats through activation of MAS receptor\/PI3K\/Akt\/BDNF pathway and inhibition of angiotensin II type-1 receptor\/NF-\u03baB axis.","volume":"15","author":"Abdallah","year":"2018","journal-title":"Biochem Pharmacol"},{"key":"20","doi-asserted-by":"publisher","first-page":"113681","DOI":"10.1016\/j.bcp.2019.113681","article-title":"Correlation between angiotensin 1-7-mediated Mas receptor expression with motor improvement, activated STAT3\/SOCS3 cascade, and suppressed HMGB-1\/RAGE\/NF-\u03baB signaling in 6-hydroxydopamine hemiparkinsonian rats.","volume":"17","author":"El-Abhar","year":"2020","journal-title":"Biochem Pharmacol"},{"key":"21","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.4103\/1673-5374.324854","article-title":"Angiotensin-(1-7) reduces \u03b1-synuclein aggregation by enhancing autophagic activity in Parkinson\u2019s disease.","volume":"1","author":"Zhang","year":"2022","journal-title":"Neural Regen Res"},{"key":"22","doi-asserted-by":"publisher","first-page":"5649","DOI":"10.3390\/ijms20225649","article-title":"Role of MicroRNAs in Parkinson\u2019s Disease.","volume":"2","author":"Tay","year":"2019","journal-title":"Int J Mol Sci"},{"key":"23","doi-asserted-by":"publisher","first-page":"519","DOI":"10.2147\/OTT.S267887","article-title":"MiR-153-3p Suppresses Cell Proliferation, Invasion and Glycolysis of Thyroid Cancer Through Inhibiting E3F3 Expression.","volume":"1","author":"Fan","year":"2021","journal-title":"Onco Targets Ther"},{"key":"24","doi-asserted-by":"publisher","first-page":"109900","DOI":"10.1016\/j.cbi.2022.109900","article-title":"MiR-203a-3p\/153-3p improves cognitive impairments induced by ischemia\/reperfusion via blockade of SRC-mediated MAPK signaling pathway in ischemic stroke.","volume":"35","author":"Li","year":"2022","journal-title":"Chem Biol Interact"},{"key":"25","doi-asserted-by":"publisher","first-page":"BSR20182485","DOI":"10.1042\/BSR20182485","article-title":"Relationship between single nucleotide polymorphisms in the 3'UTR of amyloid precursor protein and risk of Alzheimer\u2019s disease and its mechanism.","volume":"3","author":"Li","year":"2019","journal-title":"Biosci Rep"},{"key":"26","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.biopsych.2018.12.008","article-title":"MicroRNA-26a\/Death-Associated Protein Kinase 1 Signaling Induces Synucleinopathy and Dopaminergic Neuron Degeneration in Parkinson\u2019s Disease.","volume":"8","author":"Zhu","year":"2019","journal-title":"Biol Psychiatry"},{"key":"27","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12929-021-00775-x","article-title":"The role of noncoding RNAs in Parkinson\u2019s disease: biomarkers and associations with pathogenic pathways.","volume":"2","author":"Wu","year":"2021","journal-title":"J Biomed Sci"},{"key":"28","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1080\/21655979.2021.1883279","article-title":"Long non-coding RNA nuclear enriched abundant transcript 1 (NEAT1) sponges microRNA-124-3p to up-regulate phosphodiesterase 4B (PDE4B) to accelerate the progression of Parkinson\u2019s disease.","volume":"1","author":"Li","year":"2021","journal-title":"Bioengineered"},{"key":"29","doi-asserted-by":"publisher","first-page":"49688","DOI":"10.18632\/oncotarget.10434","article-title":"Long non-coding RNA-MIAT promotes neurovascular remodeling in the eye and brain.","volume":"7","author":"Yan","year":"2016","journal-title":"Oncotarget"},{"key":"30","doi-asserted-by":"publisher","first-page":"640","DOI":"10.3349\/ymj.2019.60.7.640","article-title":"Long Noncoding RNA NEAT1 Aggravates A\u03b2-Induced Neuronal Damage by Targeting miR-107 in Alzheimer\u2019s Disease.","volume":"6","author":"Liao","year":"2019","journal-title":"Yonsei Med J"},{"key":"31","doi-asserted-by":"publisher","first-page":"101878","DOI":"10.1016\/j.arr.2023.101878","article-title":"lncRNA NEAT1: Key player in neurodegenerative diseases.","volume":"8","author":"Wang","year":"2023","journal-title":"Ageing Res Rev"},{"key":"32","doi-asserted-by":"publisher","first-page":"134340","DOI":"10.1016\/j.neulet.2019.134340","article-title":"NEAT1 regulates MPP-induced neuronal injury by targeting miR-124 in neuroblastoma cells.","volume":"70","author":"Duan","year":"2019","journal-title":"Neurosci Lett"},{"key":"33","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/s11064-020-03157-1","article-title":"LncRNA NEAT1 Regulates the Development of Parkinson\u2019s Disease by Targeting AXIN1 Via Sponging miR-212-3p.","volume":"4","author":"Zhao","year":"2021","journal-title":"Neurochem Res"},{"key":"34","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.2174\/1570159X19666201223154009","article-title":"Recent Evidence in Epigenomics and Proteomics Biomarkers for Early and Minimally Invasive Diagnosis of Alzheimer\u2019s and Parkinson\u2019s Diseases.","volume":"1","author":"Ch\u00e1fer-Peric\u00e1s","year":"2021","journal-title":"Curr Neuropharmacol"},{"key":"35","doi-asserted-by":"publisher","first-page":"104515","DOI":"10.1016\/j.phrs.2019.104515","article-title":"miR-124 and Parkinson\u2019s disease: A biomarker with therapeutic potential.","volume":"15","author":"Piperi","year":"2019","journal-title":"Pharmacol Res"},{"key":"36","doi-asserted-by":"publisher","first-page":"612","DOI":"10.3389\/fnins.2018.00612","article-title":"Parkinson\u2019s Disease: Biomarkers, Treatment, and Risk Factors.","volume":"1","author":"Surguchov","year":"2018","journal-title":"Front Neurosci"},{"key":"37","doi-asserted-by":"publisher","first-page":"17455","DOI":"10.18632\/oncotarget.24736","article-title":"miRNA-based signatures in cerebrospinal fluid as potential diagnostic tools for early stage Parkinson\u2019s disease.","volume":"9","author":"Nogueira da Costa","year":"2018","journal-title":"Oncotarget"},{"key":"38","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s12943-020-01293-4","article-title":"Long non-coding RNA NEAT1 promotes bone metastasis of prostate cancer through N6-methyladenosine.","volume":"1","author":"Zhao","year":"2020","journal-title":"Mol Cancer"},{"key":"39","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.phrs.2013.03.001","article-title":"Angiotensin-(1-7) inhibits autophagy in the brain of spontaneously hypertensive rats.","volume":"7","author":"Zhang","year":"2013","journal-title":"Pharmacol Res"},{"key":"40","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s40478-015-0222-2","article-title":"Lack of additive role of ageing in nigrostriatal neurodegeneration triggered by \u03b1-synuclein overexpression.","volume":"3","author":"Li","year":"2015","journal-title":"Acta Neuropathol Commun"},{"key":"41","doi-asserted-by":"publisher","first-page":"647266","DOI":"10.3389\/fnins.2021.647266","article-title":"Dl-3-n-Butylphthalide Alleviates Behavioral and Cognitive Symptoms Via Modulating Mitochondrial Dynamics in the A53T-\u03b1-Synuclein Mouse Model of Parkinson\u2019s Disease.","volume":"1","author":"Li","year":"2021","journal-title":"Front Neurosci"},{"key":"42","doi-asserted-by":"publisher","first-page":"104538","DOI":"10.1016\/j.phrs.2019.104538","article-title":"Caffeic acid reduces A53T \u03b1-synuclein by activating JNK\/Bcl-2-mediated autophagyand improves behaviour and protects dopaminergic neurons in a mouse model of Parkinson\u2019s disease.","volume":"15","author":"Feng","year":"2019","journal-title":"Pharmacol Res"},{"key":"43","doi-asserted-by":"publisher","first-page":"7007","DOI":"10.2147\/JIR.S343575","article-title":"Angiotensin-(1-7) Analogue AVE0991 Modulates Astrocyte-Mediated Neuroinflammation via lncRNA SNHG14\/miR-223-3p\/NLRP3 Pathway and Offers Neuroprotection in a Transgenic Mouse Model of Alzheimer\u2019s Disease.","volume":"1","author":"Zhang","year":"2021","journal-title":"J Inflamm Res"},{"key":"44","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1111\/bph.14110","article-title":"Achyranthes bidentata polypeptide protects dopaminergic neurons from apoptosis in Parkinson\u2019s disease models bothand","volume":"17","author":"Sun","year":"2018","journal-title":"Br J Pharmacol"},{"key":"45","doi-asserted-by":"publisher","first-page":"9264","DOI":"10.18632\/aging.102330","article-title":"Dopaminergic neuron injury in Parkinson\u2019s disease is mitigated by interfering lncRNA SNHG14 expression to regulate the miR-133b\/ \u03b1-synuclein pathway.","volume":"1","author":"Lu","year":"2019","journal-title":"Aging (Albany NY)"},{"key":"46","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson\u2019s disease.","volume":"3","author":"Gasser","year":"2015","journal-title":"Mov Disord"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.206028","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T16:38:53Z","timestamp":1729183133000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.206028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,17]]},"references-count":46,"alternative-id":["206028"],"URL":"https:\/\/doi.org\/10.18632\/aging.206028","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,17]]}}}